Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Acute Myocardial Infarction Research, Cardiac Health and Mental Health, Antiplatelet Therapy and Cardiovascular Diseases, and Atrial Fibrillation Management and Outcomes.
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy
Abstract 4369684: Mitochondrial DNA Copy Number (mtDNA-CN): Associations with Mortality and Gene Expression in the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Biorepository
Abstract 4366483: Multi-omic Characterization of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) Trials Biorepository
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and Design
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Abstract 4124065: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Chronic Coronary Artery Disease: A Report from the ISCHEMIA Trials Biorepository
Impact of Complete Revascularization in the ISCHEMIA Trial
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease
Survival After Invasive or Conservative Management of Stable Coronary Disease
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction
Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia
Association of Factor V Leiden With Subsequent Atherothrombotic Events
Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014